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Changing of the guard
Pemphigus is a rare but debilitating blistering disease caused 
by a pathogenic autoimmune response to the desmosomal 
proteins desmoglein 1 and 3. Although high doses of corti-
costeroids are the favored treatment, recent evidence sup-
ports use of the B cell–depleting antibody rituximab to treat 
severe pemphigus. In a subsequent study of the long-term 
effects of this drug, Colliou and colleagues demonstrated that 
rituximab induced long-term complete remission in 58% of 
patients even six years after the initial infusion. In concert, 
desmoglein-specific B-cell depletion induced by the drug 
also persisted, and complete responders exhibited loss of 
anti-desmoglein-specific B cells but not B cells that respond 
to pathogens. Rituximab appears to induce a prolonged 
and continuous repopulation with naive B cells and a dis-
tinct delay in the reappearance of memory B cells. Thus, in 
some cases, rituximab actually provides a functional cure for 
pemphigus via long-term reshaping of the B-cell repertoire in 
addition to short-term loss of pathogenic autoantibodies. (Sci 
Transl Med 5:175ra30, 2013) Selected by M. Amagai
MCC family tree
Merkel cell carcinoma (MCC) is a highly malignant non-
melanoma skin cancer. It is known to be associated with the 
Merkel cell polyomavirus, but its cellular ancestry is unclear. 
Judging by marker expression patterns, MCC is most closely 
related to Merkel cells; however, mouse models have sug-
gested that epidermal stem cells or other primitive totipo-
tent stem cells are the origin of MCC. Interestingly, MCC has 
recently been shown to express early B-cell lineage mark-
ers such as terminal deoxynucleotidyl transferase (TdT), B 
cell–specific activating protein (BSAP/PAX5), and immuno-
globulin rearrangements. In a recent study, zur Hausen and 
colleagues reported TdT expression in 76.2% of MCCs and 
PAX5 expression in all of the samples. Furthermore, strong 
expression of immunoglobulins or κ/λ was detected in a sig-
nificant number of MCCs. These findings strongly suggest 
that pro-/pre- or pre-B cells are the cellular origin of MCCs 
and will probably impact treatment strategies. (Cancer Res, 
published online 10 April 2013; doi:10.1158/0008-5472/
CAN-13-0616) Selected by J. Becker
Port-wine mutation
A child born with a port-wine stain cutaneous capillary malfor-
mation on the face has a 6% chance of having Sturge–Weber 
syndrome (also known as encephalofacial angiomatosis). These 
conditions are hypothesized to result from the same underlying 
mutations, and the clinical phenotype is therefore dependent 
on where and when the somatic mutations occur during devel-
opment. In support of this hypothesis, Shirley and colleagues 
recently identified a specific somatic mosaic activating 
mutation (p.Arg183Gln) in GNAQ, which encodes a member 
of the q class of G-protein α subunits (Gαq) that mediate sig-
naling between G-protein-coupled receptors and downstream 
effectors. This mutation was associated with both Sturge–
Weber syndrome and nonsyndromic port-wine stains and 
was shown to activate downstream mitogen-activated protein 
kinase signaling. Somatic mutation of GNAQ in melanocytes 
is also associated with uveal melanoma, suggesting possible 
oncogenic potential of the identified mutation. (N Engl J Med 
368:1971–8, 2013) Selected by K. Reddy
One a day
Recurrent cellulitis episodes are particularly damaging to the 
lymphatic system and result in significant morbidity and health-
care costs. In a recent double-blind, randomized, controlled 
trial—Prophylactic Antibiotics for the Treatment of Cellulitis at 
Home I—Thomas and colleagues examined the effectiveness 
of a prophylactic 12-month course of low-dose penicillin for 
the prevention of recurrent cellulitis of the leg. In 247 patients, 
low-dose prophylactic penicillin treatment reduced the risk of 
recurrence of cellulitis by nearly half as compared with pla-
cebo treatment. Patients receiving treatment had significantly 
fewer recurrences over the follow-up period than patients 
receiving placebo, although the protection was lost by 36 
months. In addition, patients with a high body mass index, pre-
existing edema, or at least three episodes of cellulitis were less 
likely to reap the benefits of this treatment. Overall, this trial 
supports the use of prophylactic penicillin to prevent recurrent 
cellulitis, although the optimal length of prophylactic treatment 
remains to be determined. (N Engl J Med 368:1695–703, 2013) 
Selected by B. Gilchrest
Two hits are worse than one
Glomuvenous malformations (GVMs), which have been 
attributed to mutations in glomulin (GLMN) on chromosome 
1p, are characterized by autosomal dominant inheritance, 
incomplete penetrance, and high phenotypic variability, 
suggesting that an additional genetic event may be responsible 
for these venous anomalies. Amyere and colleagues 
investigated the two-hit hypothesis, which proposes that an 
association between an inherited and a somatic mutation 
underlies these abnormalities. Identification of a second 
hit in 16 of 28 lesions indicated that somatic second hits are 
necessary for the formation of GVMs and explain the variance 
in phenotype and penetrance. Interestingly, these hits were 
not typically intragenic but involved an acquired uniparental 
isodisomy (aUPID) that results in duplication of the mutant 
allele concomitant with loss of the wild-type allele without 
loss of other genes on 1p. Taken together, these results suggest 
that aUPID may even be more commonly involved in other 
noncancerous diseases, contrary to previous reports. (Am J 
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